The Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) is the leading Meeting on Hypertension and Cardiovascular Protection, where the most influential players in cardiovascular disease field come together under one roof.
Incidence and Factors Associated with Prescribing Renin-angiotensin-system Inhibitors in Adult Idiopathic Nephrotic Syndrome: A Nationwide Cohort Study
The study showed that higher baseline SBP was associated with higher likelihood of new ACEI/ARB prescription.
Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark
The study provided an overview of the temporal changes in the patient profile, medical prevention, and clinical outcomes after revascularization in patients with symptomatic PAD.
SGLT‑2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System
The study finding complements available evidence from trials supporting a protective role of SGLT2i against the occurrence of AF.
Gender Based Differences in Outcomes among Resuscitated Patients with Out-of-Hospital Cardiac Arrest
This study demonstrates the existence of gender disparities in post resuscitation care and highlights the need for future qualitative studies focused on decision-making and care being provided in the post-resuscitation phase to narrow gender-based differences in cardiac arrest outcomes.